TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal
- 1 April 2013
- journal article
- Published by Elsevier BV in Urologic Oncology: Seminars and Original Investigations
- Vol. 31 (3), 372-378
- https://doi.org/10.1016/j.urolonc.2011.02.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Transforming growth factor-β in cancer and metastasisCancer and Metastasis Reviews, 2006
- TGFβ: the molecular Jekyll and Hyde of cancerNature Reviews Cancer, 2006
- Alterations in components of the TGF-β superfamily signaling pathways in human cancerCytokine & Growth Factor Reviews, 2005
- Predictive value of expression of transforming growth factor-?1 and its receptors in transitional cell carcinoma of the urinary bladderCancer, 2001
- Role of transforming growth factor beta in cancerJournal of Cellular Physiology, 2001
- Transforming Growth Factors-beta 1 and beta 2 in Serum and Urine from Patients with Bladder CarcinomaJournal of Urology, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Review of Peptide Growth Factors in Benign Prostatic Hyperplasia and Urological MalignancyJournal of Urology, 1995
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.The Journal of cell biology, 1990